Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Supernus Pharmaceuticals (SUPN)

Supernus Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SUPN
DateTimeSourceHeadlineSymbolCompany
30/12/202421:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
30/12/202421:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
26/12/202413:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
26/12/202413:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
20/12/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SUPNSupernus Pharmaceuticals Inc
16/12/202421:30GlobeNewswire Inc.Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (viloxazine) in CanadaNASDAQ:SUPNSupernus Pharmaceuticals Inc
04/12/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
03/12/202421:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
26/11/202422:00GlobeNewswire Inc.Supernus to Participate in the 36th Annual Piper Sandler Healthcare ConferenceNASDAQ:SUPNSupernus Pharmaceuticals Inc
14/11/202422:14Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SUPNSupernus Pharmaceuticals Inc
13/11/202421:30GlobeNewswire Inc.Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare ConferenceNASDAQ:SUPNSupernus Pharmaceuticals Inc
12/11/202421:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
12/11/202421:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
08/11/202422:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
08/11/202421:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
08/11/202421:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
08/11/202421:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
07/11/202421:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
07/11/202421:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
07/11/202421:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
04/11/202421:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SUPNSupernus Pharmaceuticals Inc
04/11/202421:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SUPNSupernus Pharmaceuticals Inc
04/11/202421:05GlobeNewswire Inc.Supernus Announces Third Quarter 2024 Financial ResultsNASDAQ:SUPNSupernus Pharmaceuticals Inc
01/11/202420:35Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SUPNSupernus Pharmaceuticals Inc
31/10/202420:10GlobeNewswire Inc.Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024NASDAQ:SUPNSupernus Pharmaceuticals Inc
30/10/202420:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SUPNSupernus Pharmaceuticals Inc
21/10/202420:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SUPNSupernus Pharmaceuticals Inc
21/10/202420:25GlobeNewswire Inc.Supernus Pharmaceuticals to Host Conference Call and Webcast on November 4, 2024 to Discuss Third Quarter 2024 Financial ResultsNASDAQ:SUPNSupernus Pharmaceuticals Inc
18/10/202410:09IH Market NewsiPhone 16 Sales in China Up 20%; Sobr Safe Jumps 108% Pre-Market; Netflix and Intuitive Surgical Beat EstimatesNASDAQ:SUPNSupernus Pharmaceuticals Inc
17/10/202420:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SUPNSupernus Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SUPN